Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Nice to see we all agree on the New CR numbers, as presented

<< Previous

Bullboard Posts

Next >>

Post by Rumpl3StiltSkinon Apr 27, 2023 3:11pm

228 Views

Post# 35417719

Nice to see we all agree on the New CR numbers, as presented

Lol,

Seriously, seem to be several takes that all make some sense.

Eoga gets extra credit for his old school compile.

Bottom line is we should see a BTD application soon, with AA to follow. The CR numbers are good enough no matter how one looks....

Maybe TLT will give us some better explanations on the Swim plot in the next qtr report? :-)

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing